Topic Hub
18 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 18 of 18 clinical reviews.
Is it safe to take Praluent (alirocumab) with acetaminophen? A clinical review of pharmacokinetic and pharmacodynamic data, hepatic considerations, monitoring recommendations, and dose guidance.
Read clinical reviewIs it safe to take Praluent (alirocumab) with apixaban (Eliquis)? A detailed clinical review of pharmacokinetic and pharmacodynamic data, monitoring protocols, and prescribing considerations.
Read clinical reviewBoard-reviewed guide to the alirocumab and atorvastatin drug interaction, covering mechanism, safety data from ODYSSEY trials, monitoring needs, dose adjustments, and patient counseling.
Read clinical reviewClinical review of the interaction between alirocumab (Praluent) and benzodiazepines, covering pharmacokinetic and pharmacodynamic mechanisms, safety data, monitoring recommendations, and dose-adjustment guidance.
Read clinical reviewCan you take Praluent with estradiol HRT? A clinician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction profile, cardiovascular risk considerations, monitoring protocols, and dose-adjustment guidance for alirocumab combined with estrogen therapy.
Read clinical reviewBoard-reviewed analysis of whether alirocumab (Praluent) and finasteride can be taken together, covering CYP metabolism, pharmacodynamic overlap, lipid effects, and monitoring recommendations.
Read clinical reviewBoard-reviewed analysis of the drug interaction between alirocumab (Praluent) and proton pump inhibitors like omeprazole and pantoprazole. Covers pharmacokinetic mechanism, clinical data, and monitoring guidance.
Read clinical reviewClinical review of the drug interaction between alirocumab (Praluent) and progesterone hormone replacement therapy, including pharmacokinetic analysis, lipid effects, monitoring recommendations, and patient counseling.
Read clinical reviewClinical analysis of taking Praluent (alirocumab) with SNRIs like venlafaxine or duloxetine. Covers pharmacokinetic pathways, safety data, monitoring, and physician guidance.
Read clinical reviewClinical guide to combining alirocumab (Praluent) with testosterone replacement therapy. Covers mechanism, severity, lipid monitoring, dose adjustment, and patient counseling.
Read clinical reviewBoard-reviewed analysis of the alirocumab (Praluent) and gabapentin drug interaction, covering CYP450 pathways, renal clearance, pharmacodynamic overlap, and monitoring guidance.
Read clinical reviewIs it safe to take Praluent (alirocumab) with metformin? A clinical review of drug interaction data, pharmacokinetics, monitoring recommendations, and real-world evidence for this common combination.
Read clinical reviewCan you take Praluent (alirocumab) with rosuvastatin? A clinician-grade review of the pharmacokinetic data, clinical trial evidence, monitoring protocols, and dose-adjustment guidance for this common PCSK9 inhibitor-statin combination.
Read clinical reviewIs it safe to take alirocumab (Praluent) with sildenafil? A clinician-reviewed guide covering pharmacokinetics, cardiovascular overlap, monitoring, and dose considerations.
Read clinical reviewAlirocumab (Praluent) and tadalafil (Cialis) have no known pharmacokinetic interaction. Learn about their separate metabolic pathways, cardiovascular overlap, monitoring recommendations, and clinical evidence.
Read clinical reviewClinical analysis of the alirocumab (Praluent) and trazodone drug interaction, including mechanism, severity, monitoring parameters, and dose adjustment guidance.
Read clinical reviewCan you take Praluent (alirocumab) with warfarin? Review the pharmacokinetic and pharmacodynamic evidence, monitoring protocols, and clinical recommendations for this drug combination.
Read clinical reviewClinical review of alirocumab (Praluent) and zolpidem drug interaction risk, covering pharmacokinetic mechanisms, safety data, monitoring recommendations, and patient counseling.
Read clinical review